Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers-Reference-Cited by-同舟云学术

Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers

Published:2024-01-30 Issue:5 Volume:20 Page:3657-3658
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Algeciras‐Schimnich Alicia¹^ORCID,Bornhorst Joshua A.¹

Affiliation:

1. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Reference7 articles.

1. Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays

2. FDA permits marketing of new test to improve diagnosis of Alzheimer's disease. Accessed Jan 3 2024:www.fda.gov/new‐events/press‐announcements/fda‐permits‐marketing‐new‐test‐improve‐diagnosis‐alzheimers‐disease

3. Roche Alzheimer's disease cerebrospinal fluid (CSF) assays receive FDA clearance supporting more accurate and timely diagnosis. Accessed Jan 3 2024:https://diagnostics.roche.com/us/en/news‐listing/2022/roche‐alzheimers‐disease‐cerobrospinal‐fluid‐assays‐receive‐fda‐clearance.html

4. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

5. The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer’s Disease Cohorts;Journal of Alzheimer's Disease;2024-08-13

2. Prominent Perspective on Existing Biological Hallmarks of Alzheimer’s Disease;Current Topics in Medicinal Chemistry;2024-05

3. Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center;The Journal of Prevention of Alzheimer's Disease;2024